InvestorsHub Logo
Followers 28
Posts 4988
Boards Moderated 0
Alias Born 01/07/2020

Re: couldbebetter post# 423653

Monday, 04/29/2024 1:34:12 PM

Monday, April 29, 2024 1:34:12 PM

Post# of 424512
cbb -TalShu, Novo Nordisk ,(now the most valuable company in Europe) do not talk about this' in the official websites - or anywhere else' - but fact is that there is a critical opposition to the gigantic succes og their weight loss medicines - Wegovy (Ozempic).

If you haven't heard about this look at video here below.


--------------------------------------------

Novo Nordisk - applying the rights for Vascepa / Vazkepa could 'polish' their image and get into fighting CDV for real - for them' and their budgets - at a very affordable prize.

The fact that this drug has very little side-effects 'alone' - ought to make it worth for Novo to seriously investigate the possibility of buying Amarin.

And the fact that Vascepa / Vazkepa has shown itself to benefit patients in general health - beside CDV risk lowering chance of AZ and Cancer should make Novo Nordisk buy this company today' rather than tomorrow 🙂
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News